Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunological Synapses | 1 | 2025 | 26 | 0.940 |
Why?
|
Membrane Microdomains | 1 | 2025 | 61 | 0.920 |
Why?
|
Molecular Dynamics Simulation | 1 | 2025 | 104 | 0.890 |
Why?
|
Immunotherapy, Adoptive | 6 | 2025 | 833 | 0.800 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2020 | 483 | 0.530 |
Why?
|
T-Lymphocytes | 6 | 2025 | 1727 | 0.480 |
Why?
|
Immunotherapy | 1 | 2016 | 680 | 0.370 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2025 | 264 | 0.260 |
Why?
|
Cell Line, Tumor | 4 | 2025 | 3348 | 0.240 |
Why?
|
Zona Pellucida Glycoproteins | 1 | 2025 | 9 | 0.240 |
Why?
|
Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2025 | 25 | 0.240 |
Why?
|
CD28 Antigens | 1 | 2025 | 81 | 0.230 |
Why?
|
Receptor, ErbB-2 | 2 | 2025 | 515 | 0.220 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2025 | 234 | 0.190 |
Why?
|
Neoplasms | 1 | 2016 | 2793 | 0.190 |
Why?
|
Sarcoma | 1 | 2024 | 182 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 241 | 0.180 |
Why?
|
Leukemia, B-Cell | 1 | 2020 | 26 | 0.170 |
Why?
|
Cerebrospinal Fluid | 1 | 2020 | 93 | 0.170 |
Why?
|
Antigens, CD19 | 1 | 2020 | 177 | 0.160 |
Why?
|
Ependymoma | 1 | 2020 | 125 | 0.150 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 438 | 0.150 |
Why?
|
Cancer Vaccines | 1 | 2020 | 177 | 0.150 |
Why?
|
Medulloblastoma | 1 | 2020 | 325 | 0.130 |
Why?
|
Genetic Engineering | 1 | 2016 | 159 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2025 | 889 | 0.120 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 286 | 0.100 |
Why?
|
Signal Transduction | 1 | 2025 | 4534 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2020 | 1216 | 0.090 |
Why?
|
Animals | 5 | 2025 | 34222 | 0.080 |
Why?
|
Humans | 8 | 2025 | 125154 | 0.070 |
Why?
|
Single-Chain Antibodies | 1 | 2025 | 44 | 0.060 |
Why?
|
Vidarabine | 1 | 2024 | 80 | 0.060 |
Why?
|
B7-H1 Antigen | 1 | 2025 | 119 | 0.050 |
Why?
|
Lymphocyte Depletion | 1 | 2024 | 123 | 0.050 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2025 | 129 | 0.050 |
Why?
|
Bevacizumab | 1 | 2023 | 64 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2025 | 702 | 0.050 |
Why?
|
Mice | 3 | 2025 | 17635 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2025 | 4393 | 0.050 |
Why?
|
Cyclophosphamide | 1 | 2024 | 417 | 0.050 |
Why?
|
Pyrroles | 1 | 2023 | 182 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 12392 | 0.050 |
Why?
|
Injections, Intraventricular | 1 | 2020 | 62 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2020 | 289 | 0.040 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2023 | 512 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 186 | 0.040 |
Why?
|
Transgenes | 1 | 2020 | 336 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 581 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 1064 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2020 | 735 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 386 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 686 | 0.040 |
Why?
|
Cerebellar Neoplasms | 1 | 2020 | 275 | 0.030 |
Why?
|
Protein Binding | 1 | 2020 | 1757 | 0.030 |
Why?
|
Gene Expression | 1 | 2020 | 1561 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2020 | 2396 | 0.030 |
Why?
|
Cytokines | 1 | 2020 | 1289 | 0.030 |
Why?
|
Prospective Studies | 1 | 2024 | 6158 | 0.030 |
Why?
|
Female | 3 | 2025 | 66786 | 0.020 |
Why?
|
Biomarkers | 1 | 2020 | 3090 | 0.020 |
Why?
|
Male | 2 | 2024 | 61506 | 0.020 |
Why?
|
Aged | 1 | 2024 | 19878 | 0.020 |
Why?
|
Infant | 1 | 2020 | 12481 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 14011 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 26939 | 0.010 |
Why?
|
Adult | 1 | 2024 | 29645 | 0.010 |
Why?
|
Child | 1 | 2020 | 24393 | 0.010 |
Why?
|